{"disease":{"id":"malignancies","name":"malignancies"},"drugs":{"marketed":[{"drug_id":"filgrastim-txid","indication_name":"Febrile Neutropenia in Nonmyeloid Malignancies","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"NYPOZI","generic_name":"FILGRASTIM-TXID","company_name":"TANVEX BIOPHARMA USA INC","drug_phase":"marketed","molecular_target":"Specific cell surface receptors on hematopoietic cells","drug_class":"Leukocyte Growth Factor [EPC]","quality_score":50,"revenue":null,"mechanism":"G-CSF binds to specific receptors on hematopoietic cells, stimulating neutrophil production and function."},{"drug_id":"dactinomycin","indication_name":"Locally Recurrent or Locoregional Solid Malignancies","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cosmegen","generic_name":"DACTINOMYCIN","company_name":"Recordati","drug_phase":"marketed","molecular_target":"DNA","drug_class":"Actinomycin [EPC]","quality_score":65,"revenue":null,"mechanism":"Dactinomycin binds DNA and inhibits RNA synthesis, demonstrating cytotoxic activity in cancer models."}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05148806","title":"Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies","phase":"","overall_status":"COMPLETED","enrollment_count":28411,"lead_sponsor_name":"Imperial College London","has_results":true},{"nct_id":"NCT07283965","title":"Zanubrutinib and Acalabrutinib Use and Risk of Atrial Fibrillation in Patients With Chronic B-cell Malignancies","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":15000,"lead_sponsor_name":"University Hospital, Caen","has_results":false},{"nct_id":"NCT06561243","title":"Ibrutinib and Acalabrutinib Use and Risk of Atrial Fibrillation in Patients With Chronic B-cell Malignancies","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":15000,"lead_sponsor_name":"University Hospital, Caen","has_results":false},{"nct_id":"NCT02457962","title":"Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05602103","title":"Cancer Therapy-related Cardiac Dysfunction Occuring in Children Treated by Anticancer Drugs for Malignancies","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"University Hospital, Caen","has_results":false},{"nct_id":"NCT04142372","title":"Tissue Microarray of Hematological Malignancies","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Tampere University Hospital","has_results":false},{"nct_id":"NCT03486873","title":"Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":3500,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT04733729","title":"Covid-19 in Hematological Malignancies","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne","has_results":false},{"nct_id":"NCT01345019","title":"Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1718,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT06703853","title":"Identifying Tissue-of-origin in Transplant Patients and Patients with Malignancies.","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Hadassah Medical Organization","has_results":false},{"nct_id":"NCT06550102","title":"Drug Response Profiling (DRP) Registry Zurich for Hematological Malignancies","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University Children's Hospital, Zurich","has_results":false},{"nct_id":"NCT06607289","title":"National Longitudinal Cohort of Hematological Diseases (NICHE) - CART","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT02473757","title":"Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1000,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT01700959","title":"Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":911,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":true},{"nct_id":"NCT07303387","title":"Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors.","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":900,"lead_sponsor_name":"Gustave Roussy, Cancer Campus, Grand Paris","has_results":false},{"nct_id":"NCT03084471","title":"An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":867,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT05417594","title":"Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":695,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT01375842","title":"A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PDL1] Antibody) to Evaluate Safety, Tolerability and Pharmacokinetics in Participants With Locally Advanced or Metastatic Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":661,"lead_sponsor_name":"Genentech, Inc.","has_results":false},{"nct_id":"NCT06674330","title":"Using a Population Pharmacokinetic Model to Estimate the Dosage of Teicoplanin in Patients With Hematologic Malignancy or Critical Illness","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT00585195","title":"A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":596,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT06468098","title":"A Study of IBI363 in Subjects With Advanced Malignancies","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":556,"lead_sponsor_name":"Innovent Biologics (Suzhou) Co. Ltd.","has_results":false},{"nct_id":"NCT04634552","title":"A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":510,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT05103995","title":"Impact of Donor-recipient ABO Matching on Haploidentical Stem Cell Transplantation","phase":"","overall_status":"COMPLETED","enrollment_count":510,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false},{"nct_id":"NCT06296368","title":"DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics","phase":"NA","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"UNC Lineberger Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT02315599","title":"Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":500,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04389541","title":"Clinical Research Platform on Decision Making and Clinical Impact of Biomarker-Driven Precision Oncology","phase":"","overall_status":"COMPLETED","enrollment_count":499,"lead_sponsor_name":"iOMEDICO AG","has_results":false},{"nct_id":"NCT04835675","title":"AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Hepatobiliary Cancer Malignancies","phase":"","overall_status":"COMPLETED","enrollment_count":496,"lead_sponsor_name":"Zhujiang Hospital","has_results":false},{"nct_id":"NCT04728893","title":"Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":490,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT06151028","title":"An Observational Study of Menopausal Symptom in Patients With Gynecological Malignancy After Oophorectomy","phase":"","overall_status":"RECRUITING","enrollment_count":490,"lead_sponsor_name":"Anhui Provincial Hospital","has_results":false},{"nct_id":"NCT07104175","title":"Predictive Value of NRS2002 and GLIM for Complications After GI Malignancy Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":471,"lead_sponsor_name":"Third central hospital of Tianjin affiliated Nankai university","has_results":false},{"nct_id":"NCT04277637","title":"Study of Bcl-2 Inhibitor Sonrotoclax (BGB-11417) in Participants With Mature B-Cell Malignancies","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":437,"lead_sponsor_name":"BeOne Medicines","has_results":false},{"nct_id":"NCT02964325","title":"Efficacy of Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative Thrombocytopenia","phase":"NA","overall_status":"TERMINATED","enrollment_count":422,"lead_sponsor_name":"Terumo BCTbio","has_results":true},{"nct_id":"NCT07220616","title":"A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":420,"lead_sponsor_name":"Daiichi Sankyo","has_results":false},{"nct_id":"NCT02383212","title":"Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":398,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT02343120","title":"Study of the Safety and Pharmacokinetics of BGB-3111 in Subjects With B-Cell Lymphoid Malignancies","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":385,"lead_sponsor_name":"BeiGene","has_results":true},{"nct_id":"NCT04164134","title":"New Strategies to Detect Cancers in Carriers of Mutations in RB1","phase":"","overall_status":"COMPLETED","enrollment_count":378,"lead_sponsor_name":"Amsterdam UMC, location VUmc","has_results":false},{"nct_id":"NCT00040222","title":"Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":377,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT07480005","title":"To Revisit the Yield of Staging Laparoscopy in Hepatopancreatobiliary Malignancies","phase":"","overall_status":"RECRUITING","enrollment_count":350,"lead_sponsor_name":"Institute of Liver and Biliary Sciences, India","has_results":false},{"nct_id":"NCT07022002","title":"SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":340,"lead_sponsor_name":"Shenyang Sunshine Pharmaceutical Co., LTD.","has_results":false},{"nct_id":"NCT03005782","title":"Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":333,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT04916119","title":"Study of IBI323 in Patients With Advanced Malignancies","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":322,"lead_sponsor_name":"Innovent Biologics (Suzhou) Co. Ltd.","has_results":false},{"nct_id":"NCT05290545","title":"Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCT","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":314,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT02740985","title":"A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":313,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT07136779","title":"First-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor Malignancies","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":310,"lead_sponsor_name":"VelaVigo Bio Inc","has_results":false},{"nct_id":"NCT02327078","title":"A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":307,"lead_sponsor_name":"Incyte Corporation","has_results":true},{"nct_id":"NCT03145181","title":"Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":302,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT04878822","title":"Immunogenicity of Covid-19 Vaccination for Patients With Hematological Malignancies","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Ospedale di Circolo - Fondazione Macchi","has_results":false},{"nct_id":"NCT03314974","title":"Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT07448922","title":"A Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":290,"lead_sponsor_name":"Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.","has_results":false},{"nct_id":"NCT01607892","title":"Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":286,"lead_sponsor_name":"Karyopharm Therapeutics Inc","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}